IS8090A - Samsetning til að bæta vitsmuni og minni - Google Patents

Samsetning til að bæta vitsmuni og minni

Info

Publication number
IS8090A
IS8090A IS8090A IS8090A IS8090A IS 8090 A IS8090 A IS 8090A IS 8090 A IS8090 A IS 8090A IS 8090 A IS8090 A IS 8090A IS 8090 A IS8090 A IS 8090A
Authority
IS
Iceland
Prior art keywords
wit
memory
composition
improve
improve wit
Prior art date
Application number
IS8090A
Other languages
English (en)
Inventor
Zisapel Nava
Laudon Moshe
Original Assignee
Neurim Pharmaceuticals (1991) Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurim Pharmaceuticals (1991) Ltd. filed Critical Neurim Pharmaceuticals (1991) Ltd.
Publication of IS8090A publication Critical patent/IS8090A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS8090A 2003-04-29 2005-10-25 Samsetning til að bæta vitsmuni og minni IS8090A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL155666A IL155666A (en) 2003-04-29 2003-04-29 Insomnia treatment
PCT/IL2004/000330 WO2004096118A2 (en) 2003-04-29 2004-04-15 Composition for improving cognition and memory

Publications (1)

Publication Number Publication Date
IS8090A true IS8090A (is) 2005-10-25

Family

ID=33397641

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8090A IS8090A (is) 2003-04-29 2005-10-25 Samsetning til að bæta vitsmuni og minni

Country Status (28)

Country Link
US (2) US8859593B2 (is)
EP (1) EP1620058B1 (is)
JP (2) JP4981440B2 (is)
KR (1) KR101136885B1 (is)
CN (1) CN1787820B (is)
AR (1) AR048370A1 (is)
AT (1) ATE539746T1 (is)
BR (1) BRPI0409935A (is)
CA (1) CA2521182C (is)
CL (1) CL2004000877A1 (is)
CY (1) CY1112689T1 (is)
DK (1) DK1620058T3 (is)
EA (1) EA008768B1 (is)
ES (1) ES2380364T3 (is)
IL (1) IL155666A (is)
IS (1) IS8090A (is)
MX (1) MXPA05011590A (is)
NO (1) NO333015B1 (is)
NZ (1) NZ542724A (is)
PE (1) PE20050144A1 (is)
PL (1) PL1620058T3 (is)
PT (1) PT1620058E (is)
SI (1) SI1620058T1 (is)
TW (1) TWI340037B (is)
UA (1) UA87980C2 (is)
UY (1) UY28296A1 (is)
WO (1) WO2004096118A2 (is)
ZA (1) ZA200509508B (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL155666A (en) * 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
JP4993900B2 (ja) * 2005-11-28 2012-08-08 国立大学法人 東京医科歯科大学 記憶障害抑制剤
US8372876B2 (en) * 2007-03-06 2013-02-12 The University Of Houston System Method for improving memory in mammals
US8940326B2 (en) 2007-03-19 2015-01-27 Vita Sciences Llc Transdermal patch and method for delivery of vitamin B12
BRPI0811052A2 (pt) 2007-04-12 2015-01-27 Univ Minnesota Composições de proteção de isquemia/reperfusão e métodos de uso.
KR102593047B1 (ko) 2012-01-26 2023-10-24 반다 파마슈티칼즈, 인코퍼레이티드. 일주기 리듬 장애의 치료
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
WO2014100292A1 (en) * 2012-12-18 2014-06-26 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
CA2975985A1 (fr) * 2015-02-04 2016-08-11 Soeur Josefa Menendez Systeme therapeutique transdermique contenant de la valentonine et son utilisation comme medicament
US10307398B2 (en) 2016-09-20 2019-06-04 Regents Of The University Of Minnesota Resuscitation composition and methods of making and using
KR102499141B1 (ko) * 2016-10-31 2023-02-13 신신제약 주식회사 수면장애 치료용 경피흡수제제
US10849856B2 (en) 2016-10-31 2020-12-01 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same
SG11201903829PA (en) 2016-10-31 2019-05-30 Neurim Pharma 1991 Melatonin mini-tablets and method of manufacturing the same

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US468017A (en) * 1892-02-02 Lock-case
US4506080A (en) 1983-07-01 1985-03-19 Nestec S. A. Preparation of serotonine and derivatives
US4965074A (en) 1985-03-05 1990-10-23 Ciba-Geigy Corporation Method of treating memory impairment
US4765985A (en) 1985-03-05 1988-08-23 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
DE3775830D1 (de) 1986-06-13 1992-02-20 Alza Corp Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
DE3639418A1 (de) 1986-11-18 1988-06-09 Forschungsgesellschaft Rauchen Nikotinhaltiges mittel
PT100973A (pt) 1991-10-18 1994-06-30 Alza Corp Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
AU671093B2 (en) * 1992-01-07 1996-08-15 Elan Pharmaceuticals, Inc. Transgenic animal models for alzheimer's disease
DK0565296T3 (da) 1992-04-07 1996-12-09 Neurim Pharma 1991 Anvendelse af melatonin til fremstilling af et lægemiddel til behandling af godartet prostatahyperplasi
US5449683A (en) * 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin
GB9310412D0 (en) 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
WO1995001766A1 (en) 1993-07-09 1995-01-19 Cygnus Therapeutic Systems Method and device for providing nicotine replacement therapy transdermally/transbuccally
CA2187023A1 (en) 1994-04-13 1995-10-26 Steven Andrew Giannos Temporally controlled drug delivery systems
US5863902A (en) 1995-01-06 1999-01-26 Sibia Neurosciences, Inc. Methods of treating neurodegenerative disorders using protease inhibitors
MD1716C2 (ro) 1995-02-01 2002-02-28 Neurim Pharmaceuticals (1991) Ltd. Utilizare a melatoninei pentru tratamentul pacienţilor dependenţi de benzodiazepine
US5696115A (en) * 1995-04-21 1997-12-09 Eli Lilly And Company Method for treating nicotine withdrawal
US5700828A (en) 1995-12-07 1997-12-23 Life Resuscitation Technologies, Inc. Treatment or prevention of anoxic or ischemic brain injury with melatonin-containing compositions
JP3707798B2 (ja) 1996-05-13 2005-10-19 ノバルティス・コンシューマー・ヘルス・ソシエテ・アノニム 口内薬剤輸送系
FR2762993B1 (fr) * 1997-05-06 1999-08-13 Inst Rech Biolog Sa Nouvelle utilisation de phospholipides d'origine animale en therapeutique et/ou dietetique
WO1998054189A1 (en) 1997-05-30 1998-12-03 Neurosearch A/S Spiro-quinuclidine derivatives, their preparation and use
WO1999048489A2 (en) * 1998-03-25 1999-09-30 South Alabama Medical Science Foundation Melatonin for delaying the onset of alzheimer's disease and for treating or delaying the onset of other amyloidosis-related diseases/disorders
US6353015B1 (en) * 1998-08-26 2002-03-05 St. Elizabeth's Medical Center Method of treating neurodegenerative disorders
RU2134108C1 (ru) 1998-10-06 1999-08-10 Заславская Рина Михайловна Средство для лечения артериальной гипертонии, способ лечения артериальной гипертонии
FR2788982B1 (fr) * 1999-02-02 2002-08-02 Synthelabo Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique
CA2359640C (en) * 1999-02-05 2008-11-18 Cipla Limited Topical sprays
US6353051B1 (en) 1999-03-10 2002-03-05 E. I. Du Pont De Nemours And Company Top coating for synthetic leathers
PT1272177E (pt) 2000-01-05 2007-07-11 Neurim Pharma 1991 Método e formulação para o tratamento da resistência aos antihipertensos e condições associadas.
EP2133078A1 (en) * 2000-03-03 2009-12-16 Eisai R&D Management Co., Ltd. Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments
DE10013712A1 (de) 2000-03-20 2001-09-27 Nutrinova Gmbh Nikotinsalze mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung
WO2002016357A2 (en) * 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
PL364621A1 (en) 2001-03-26 2004-12-13 Smithkline Beecham Corporation Nicotine-containing oral dosage form
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
ATE276676T1 (de) * 2001-10-22 2004-10-15 Ivo Pera Zusammensetzung zur reduzierung oder entwöhnung von nikotinabhängigkeit
US7113651B2 (en) 2002-11-20 2006-09-26 Dmetrix, Inc. Multi-spectral miniature microscope array
IL155666A (en) * 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment

Also Published As

Publication number Publication date
CL2004000877A1 (es) 2005-01-07
WO2004096118B1 (en) 2005-12-01
EA200501666A1 (ru) 2006-06-30
PE20050144A1 (es) 2005-05-12
NO20055531L (no) 2005-11-23
PL1620058T3 (pl) 2012-07-31
CY1112689T1 (el) 2016-02-10
TW200501948A (en) 2005-01-16
CN1787820A (zh) 2006-06-14
UY28296A1 (es) 2004-11-30
TWI340037B (en) 2011-04-11
JP2006525317A (ja) 2006-11-09
ATE539746T1 (de) 2012-01-15
CN1787820B (zh) 2010-05-05
WO2004096118A3 (en) 2005-10-13
NO333015B1 (no) 2013-02-18
JP2012116859A (ja) 2012-06-21
NZ542724A (en) 2007-05-31
HK1087635A1 (zh) 2006-10-20
DK1620058T3 (da) 2012-05-07
ES2380364T3 (es) 2012-05-11
EA008768B1 (ru) 2007-08-31
AR048370A1 (es) 2006-04-26
BRPI0409935A (pt) 2006-04-25
US20140378512A1 (en) 2014-12-25
EP1620058B1 (en) 2012-01-04
UA87980C2 (ru) 2009-09-10
PT1620058E (pt) 2012-04-13
EP1620058A2 (en) 2006-02-01
ZA200509508B (en) 2006-11-29
SI1620058T1 (sl) 2012-05-31
JP4981440B2 (ja) 2012-07-18
KR20060005402A (ko) 2006-01-17
KR101136885B1 (ko) 2012-04-20
WO2004096118A2 (en) 2004-11-11
IL155666A0 (en) 2004-09-27
EP1620058A4 (en) 2006-07-26
IL155666A (en) 2013-12-31
CA2521182A1 (en) 2004-11-11
CA2521182C (en) 2011-05-31
MXPA05011590A (es) 2006-03-08
US8859593B2 (en) 2014-10-14
US20060229340A1 (en) 2006-10-12

Similar Documents

Publication Publication Date Title
NO20054789D0 (no) Sammensetninger inneholdende piperaciliin og tazobactam nytting for injeksjon
DK1765327T3 (da) Forbindelser, sammensætninger og fremgangsmåder
DK1567112T3 (da) Thiazolidin-4-oner til at hæmme hYAK3-proteiner
DK1751087T3 (da) Levodopa-derivater og sammensætninger og anvendelser deraf
DK1715893T3 (da) Direkte kompressionsformulering og fremgangsmåde
DE60317699D1 (de) Fermentationsverfahren und -zusammensetzungen
DK1583542T3 (da) Sammensætninger og fremgangsmåder til antiviral kombinationsterapi
FR2842417B1 (fr) Composition cosmetique
FR2842416B1 (fr) Composition cosmetique
DE10393374D2 (de) Zusammensetzung
EP1701725A4 (en) PROCESS AND COMPOSITIONS
IS8090A (is) Samsetning til að bæta vitsmuni og minni
DK1561472T3 (da) Faststofsammensætning
DK1937276T3 (da) Forbedret testosterongel og fremgangsmåde til anvendelse deraf
DK1601744T3 (da) Forgasningsapparat og fremgangsmåde
DE60329687D1 (de) Topische wasser-und ethanolfreie Pimecrolimus enthaltende Zusammensetzungen
DE602004018936D1 (de) Härtbare zusammensetzung
DK1814977T3 (da) Arthrospira-baserede sammensætninger og anvendelser deraf
SE0500163L (sv) Sammansättning
DE60320975D1 (de) Hydrospeicher
DE60304501D1 (de) Rostschutzzusammensetzung
DK1840121T3 (da) Glycinderivat og anvendelse heraf
DE602004009078D1 (de) Speicherordnung
DE60321010D1 (de) Scan-testbarer FIFO-Speicher
EP1561467A4 (en) COMPOSITION FOR RECOVERING DAMAGED SKIN